178 related articles for article (PubMed ID: 34359601)
1. Targeted Oral Delivery of Paclitaxel Using Colostrum-Derived Exosomes.
Kandimalla R; Aqil F; Alhakeem SS; Jeyabalan J; Tyagi N; Agrawal A; Yan J; Spencer W; Bondada S; Gupta RC
Cancers (Basel); 2021 Jul; 13(15):. PubMed ID: 34359601
[TBL] [Abstract][Full Text] [Related]
2. Milk-derived exosomes for oral delivery of paclitaxel.
Agrawal AK; Aqil F; Jeyabalan J; Spencer WA; Beck J; Gachuki BW; Alhakeem SS; Oben K; Munagala R; Bondada S; Gupta RC
Nanomedicine; 2017 Jul; 13(5):1627-1636. PubMed ID: 28300659
[TBL] [Abstract][Full Text] [Related]
3. Exosomal delivery of berry anthocyanidins for the management of ovarian cancer.
Aqil F; Jeyabalan J; Agrawal AK; Kyakulaga AH; Munagala R; Parker L; Gupta RC
Food Funct; 2017 Nov; 8(11):4100-4107. PubMed ID: 28991298
[TBL] [Abstract][Full Text] [Related]
4. Combination Therapy Comprising Paclitaxel and 5-Fluorouracil by Using Folic Acid Functionalized Bovine Milk Exosomes Improves the Therapeutic Efficacy against Breast Cancer.
Kumar DN; Chaudhuri A; Dehari D; Shekher A; Gupta SC; Majumdar S; Krishnamurthy S; Singh S; Kumar D; Agrawal AK
Life (Basel); 2022 Jul; 12(8):. PubMed ID: 36013322
[TBL] [Abstract][Full Text] [Related]
5. Exosomal formulation enhances therapeutic response of celastrol against lung cancer.
Aqil F; Kausar H; Agrawal AK; Jeyabalan J; Kyakulaga AH; Munagala R; Gupta R
Exp Mol Pathol; 2016 Aug; 101(1):12-21. PubMed ID: 27235383
[TBL] [Abstract][Full Text] [Related]
6. Paclitaxel Has a Reduced Toxicity Profile in Healthy Rats After Polymeric Micellar Nanoparticle Delivery.
Lu J; Lou Y; Zhang Y; Zhong R; Zhang W; Zhang X; Wang H; Chu T; Han B; Zhong H
Int J Nanomedicine; 2023; 18():263-276. PubMed ID: 36660338
[TBL] [Abstract][Full Text] [Related]
7. Milk/colostrum exosomes: A nanoplatform advancing delivery of cancer therapeutics.
Wallen M; Aqil F; Spencer W; Gupta RC
Cancer Lett; 2023 May; 561():216141. PubMed ID: 36963459
[TBL] [Abstract][Full Text] [Related]
8. Targeted Therapy of Lung Adenocarcinoma by the Nanoplatform Based on Milk Exosomes Loaded with Paclitaxel.
Chen J; Cao F; Cao Y; Wei S; Zhu X; Xing W
J Biomed Nanotechnol; 2022 Apr; 18(4):1075-1083. PubMed ID: 35854459
[TBL] [Abstract][Full Text] [Related]
9. Exosomal formulation of anthocyanidins against multiple cancer types.
Munagala R; Aqil F; Jeyabalan J; Agrawal AK; Mudd AM; Kyakulaga AH; Singh IP; Vadhanam MV; Gupta RC
Cancer Lett; 2017 May; 393():94-102. PubMed ID: 28202351
[TBL] [Abstract][Full Text] [Related]
10. Synergistic combinations of paclitaxel and withaferin A against human non-small cell lung cancer cells.
Kyakulaga AH; Aqil F; Munagala R; Gupta RC
Oncotarget; 2020 Apr; 11(16):1399-1416. PubMed ID: 32362998
[TBL] [Abstract][Full Text] [Related]
11. Antitumor activity of paclitaxel is significantly enhanced by a novel proapoptotic agent in non-small cell lung cancer.
Razi SS; Rehmani S; Li X; Park K; Schwartz GS; Latif MJ; Bhora FY
J Surg Res; 2015 Apr; 194(2):622-630. PubMed ID: 25498514
[TBL] [Abstract][Full Text] [Related]
12. Synergistic antitumor effect of α-pinene and β-pinene with paclitaxel against non-small-cell lung carcinoma (NSCLC).
Zhang Z; Guo S; Liu X; Gao X
Drug Res (Stuttg); 2015 Apr; 65(4):214-8. PubMed ID: 25188609
[TBL] [Abstract][Full Text] [Related]
13. Exosomes for the Enhanced Tissue Bioavailability and Efficacy of Curcumin.
Aqil F; Munagala R; Jeyabalan J; Agrawal AK; Gupta R
AAPS J; 2017 Nov; 19(6):1691-1702. PubMed ID: 29047044
[TBL] [Abstract][Full Text] [Related]
14. Comparing nanoparticle polymeric micellar paclitaxel and solvent-based paclitaxel as first-line treatment of advanced non-small-cell lung cancer: an open-label, randomized, multicenter, phase III trial.
Shi M; Gu A; Tu H; Huang C; Wang H; Yu Z; Wang X; Cao L; Shu Y; Wang H; Yang R; Li X; Chang J; Hu Y; Shen P; Hu Y; Guo Z; Tao M; Zhang Y; Liu X; Sun Q; Zhang X; Jiang Z; Zhao J; Chen F; Yu H; Zhang W; Sun J; Li D; Zhou J; Han B; Wu YL
Ann Oncol; 2021 Jan; 32(1):85-96. PubMed ID: 33130217
[TBL] [Abstract][Full Text] [Related]
15. Paclitaxel and di-fluorinated curcumin loaded in albumin nanoparticles for targeted synergistic combination therapy of ovarian and cervical cancers.
Gawde KA; Sau S; Tatiparti K; Kashaw SK; Mehrmohammadi M; Azmi AS; Iyer AK
Colloids Surf B Biointerfaces; 2018 Jul; 167():8-19. PubMed ID: 29625422
[TBL] [Abstract][Full Text] [Related]
16. Milk exosomes - Natural nanoparticles for siRNA delivery.
Aqil F; Munagala R; Jeyabalan J; Agrawal AK; Kyakulaga AH; Wilcher SA; Gupta RC
Cancer Lett; 2019 May; 449():186-195. PubMed ID: 30771430
[TBL] [Abstract][Full Text] [Related]
17. Co-delivery of cisplatin and paclitaxel by folic acid conjugated amphiphilic PEG-PLGA copolymer nanoparticles for the treatment of non-small lung cancer.
He Z; Huang J; Xu Y; Zhang X; Teng Y; Huang C; Wu Y; Zhang X; Zhang H; Sun W
Oncotarget; 2015 Dec; 6(39):42150-68. PubMed ID: 26517524
[TBL] [Abstract][Full Text] [Related]
18. Safe and Targeted Sonodynamic Cancer Therapy Using Biocompatible Exosome-Based Nanosonosensitizers.
Nguyen Cao TG; Kang JH; You JY; Kang HC; Rhee WJ; Ko YT; Shim MS
ACS Appl Mater Interfaces; 2021 Jun; 13(22):25575-25588. PubMed ID: 34033477
[TBL] [Abstract][Full Text] [Related]
19. Bovine milk-derived exosomes for drug delivery.
Munagala R; Aqil F; Jeyabalan J; Gupta RC
Cancer Lett; 2016 Feb; 371(1):48-61. PubMed ID: 26604130
[TBL] [Abstract][Full Text] [Related]
20. Trimethyl chitosan based conjugates for oral and intravenous delivery of paclitaxel.
He R; Yin C
Acta Biomater; 2017 Apr; 53():355-366. PubMed ID: 28189812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
